Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 3
2004 2
2005 3
2006 7
2007 6
2008 5
2009 5
2010 15
2011 13
2012 16
2013 10
2014 11
2015 20
2016 18
2017 24
2018 27
2019 27
2020 25
2021 48
2022 40
2023 45
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

334 results

Results by year

Filters applied: . Clear all
Page 1
The wide world of technological telerehabilitation for pediatric neurologic and neurodevelopmental disorders - a systematic review.
Del Lucchese B, Parravicini S, Filogna S, Mangani G, Beani E, Di Lieto MC, Bardoni A, Bertamino M, Papini M, Tacchino C, Fedeli F, Cioni G, Sgandurra G; Italian Neuroscience and Neurorehabilitation Network. Del Lucchese B, et al. Front Public Health. 2024 Apr 17;12:1295273. doi: 10.3389/fpubh.2024.1295273. eCollection 2024. Front Public Health. 2024. PMID: 38694988 Free PMC article.
The role of stroke-induced immunosuppression as a predictor of functional outcome in the neurorehabilitation setting.
Vaghi G, Morotti A, Piella EM, Avenali M, Martinelli D, Cristina S, Allena M, Grillo V, Corrado M, Bighiani F, Cammarota F, Antoniazzi A, Ferrari F, Mazzacane F, Cavallini A, Pichiecchio A, Rognone E, Martinis L, Correale L, Castiglia SF, Trabassi D, Serrao M, Tassorelli C, De Icco R. Vaghi G, et al. Among authors: tassorelli c. Sci Rep. 2024 Apr 9;14(1):8320. doi: 10.1038/s41598-024-58562-1. Sci Rep. 2024. PMID: 38594322 Free PMC article.
Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injury.
Ashina H, Diener HC, Tassorelli C, Scher AI, Lipton RB, Pozo-Rosich P, Sinclair AJ, Chong CD, Finkel AG, Ashina M, Schwedt TJ, Dodick DW, Terwindt GM. Ashina H, et al. Among authors: tassorelli c. Cephalalgia. 2024 Mar;44(3):3331024241234068. doi: 10.1177/03331024241234068. Cephalalgia. 2024. PMID: 38518177 Free article. Review.
National plans and awareness campaigns as priorities for achieving global brain health.
Winter SF, Walsh D, Catsman-Berrevoets C, Feigin V, Destrebecq F, Dickson SL, Leonardi M, Hoemberg V, Tassorelli C, Ferretti MT, Dé A, Chadha AS, Lynch C, Bakhtadze S, Saylor D, Hwang S, Rostasy K, Kluger BM, Wright C, Zee PC, Dodick DW, Jaarsma J, Owolabi MO, Zaletel J, Albreht T, Dhamija RK, Helme A, Laurson-Doube J, Amos A, Baingana FK, Baker GA, Sofia F, Galvin O, Hawrot T. Winter SF, et al. Among authors: tassorelli c. Lancet Glob Health. 2024 Apr;12(4):e697-e706. doi: 10.1016/S2214-109X(23)00598-3. Lancet Glob Health. 2024. PMID: 38485433 Free PMC article. Review.
Comparative efficacy, quality of life, safety, and tolerability of atogepant and rimegepant in migraine prevention: A matching-adjusted indirect comparison analysis.
Tassorelli C, Onishchenko K, Halker Singh RB, Duan M, Dupont-Benjamin L, Hemstock M, Voller C, McAllister P, Nahas SJ, Gandhi P, Ailani J. Tassorelli C, et al. Cephalalgia. 2024 Feb;44(2):3331024241235156. doi: 10.1177/03331024241235156. Cephalalgia. 2024. PMID: 38410850 Free article. Review.
International Classification of Headache Disorders-4 - Work in Progress 1.
Goadsby PJ, Evers S, Gelfand AA, Lipton RB, May A, Pozo-Rosich P, Schoenen J, Schwedt TJ, Tassorelli C, Terwindt G, Wang SJ. Goadsby PJ, et al. Among authors: tassorelli c. Cephalalgia. 2024 Feb;44(2):3331024241233937. doi: 10.1177/03331024241233937. Cephalalgia. 2024. PMID: 38388354 Free article. No abstract available.
Safety and efficacy of atogepant for the preventive treatment of episodic migraine in adults for whom conventional oral preventive treatments have failed (ELEVATE): a randomised, placebo-controlled, phase 3b trial.
Tassorelli C, Nagy K, Pozo-Rosich P, Lanteri-Minet M, Sacco S, Nežádal T, Guo H, De Abreu Ferreira R, Forero G, Trugman JM. Tassorelli C, et al. Lancet Neurol. 2024 Apr;23(4):382-392. doi: 10.1016/S1474-4422(24)00025-5. Epub 2024 Feb 13. Lancet Neurol. 2024. PMID: 38364831 Clinical Trial.
334 results